Vaccines to combat emerging infectious diseases such as Ebola or Zika may become too expensive because safeguards ensuring fair pricing have been watered down, campaigners are warning.
In an open letter to the Coalition for Epidemic Preparedness (Cepi) – set up to develop vaccines against deadly but neglected infectious diseases – charity Medecins sans Frontieres warns that the coalition has taken an “alarming step backwards” in its new equitable access policy.
The policy “no longer guarantees that he vaccines Cepi funds will be made available at an affordable price”, the charity warns.
MSF says that Cepi has removed pledges in its policy to make vaccine prices as low as possible and as well as ensure transparency of pricing.
Cepi has also said that its board will no longer oversee contracts – instead Cepi staff will summarise partnership agreements for the board “providing a detailed description of all access provisions”.